Notice Pursuant to the National Cooperative Research and Production Act of 1993-Biopharmaceutical Manufacturing Preparedness Consortium, 10946-10947 [2025-03217]
Download as PDF
<![CDATA[
khammond on DSK9W7S144PROD with NOTICES
10946
Federal Register / Vol. 90, No. 39 / Friday, February 28, 2025 / Notices
Valley, CA; TerminusDB, Dublin,
IRELAND; Data Science Salon, Miami,
FL; MLOps Community, Flagstaff, AZ;
Molecula, Austin, TX; Activeloop,
Mountain View, CA; Superwise AI
LTD., Tel Aviv, STATE OF ISRAEL;
LGN Innovations Inc., St Asaph,
IRELAND; Superb AI, Inc., San Mateo,
CA; YData Labs Inc., Seattle, WA;
InfuseAI Inc., Taipei City, TAIWAN;
Seldon Technologies Limited, London,
UNITED KINGDOM; Modzy, Inc.,
Vienna, VA; TheSequence, Coral Gables,
FL; Iguazio, Herzliya, STATE OF
ISRAEL; Valohai, Turku, REPUBLIC OF
FINLAND; Nvidia, Inc., Santa Clara, CA;
Data-Centric AI Community, Seattle,
WA; WhyLabs Inc., Seattle, WA; Pasteur
Labs & ISI, Brooklyn, NY; Fiddler AI,
Palo Alto, CA; Hewlett Packard
Enterprise, San Jose, CA; Toloka AI Inc.,
Wilmington, DE; TruEra, Inc., Redwood
City, CA; Bosch AIShield, Koramangala,
REPUBLIC OF INDIA; Run:ai, Tel Aviv,
STATE OF ISRAEL; Galileo
Technologies, San Francisco, CA;
Modulos AG, Zurich, SWISS
CONFEDERATION; AI Partnerships
Corp., Toronto, CANADA; Weights and
Biases, Inc., San Francisco, CA; Kognic
AB, Gothenburg, KINGDOM OF
SWEDEN; Manot, Inc., Glendale, CA;
Fennel AI, Menlo Park, CA; Arthur,
New York, NY; MakinaRocks, Seoul,
REPUBLIC OF KOREA; Colorado
College, Colorado Springs, CO;
Çukurova University, Industrial
Engineering Department, Adana,
REPUBLIC OF TÜRKIYE; SEMATIC,
San Francisco, CA; and deepset GmbH,
Berlin, FEDERAL REPUBLIC OF
GERMANY, have withdrawn as parties
to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
On January 5, 2022, AIIA filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on March 10, 2022 (87 FR 13759).
The last notification was filed with
the Department on October 26, 2023. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on December 15, 2023 (88 FR
86931).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2025–03206 Filed 2–27–25; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
16:18 Feb 27, 2025
Jkt 265001
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Senior Healthcare
Innovation Consortium
Notice is hereby given that, on
January 28, 2025, pursuant to section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Senior Healthcare Innovation
Consortium (SHIC) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, QHSLab, Inc., West Palm
Beach, FL has been added as a party to
this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and SHIC intends
to file additional written notifications
disclosing all changes in membership.
November 02, 2022, SHIC filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on November 23, 2022 (87 FR
71677).
The last notification was filed with
the Department on October 3, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on December 20, 2024 (89 FR
104210).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2025–03218 Filed 2–27–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Biopharmaceutical
Manufacturing Preparedness
Consortium
Notice is hereby given that, on
January 14, 2025, pursuant to section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Biopharmaceutical Manufacturing
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
Preparedness Consortium (‘‘BioMaPConsortium’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Bella Biologics, Inc.,
Cohoes, NY; Biotech Resources Group
LLC, Gaithersburg, MD; CellCo, San
Francisco, CA; Mercury Bio, Inc., Santa
Fe, NM; Meridian Medical Technologies
LLC, Columbia, MD; National Institute
for Pharmaceutical Technology and
Education, Inc., Minneapolis, MN;
Noramco LLC, Wilmington, DE;
PATHOLOGY ASSIST–TEMP, INC.,
Chantilly, VA; Parkdale Advanced
Materials, Inc., Gastonia, NC; Purisys
LLC, Athens, GA; QYK BRANDS LLC,
GARDEN GROVE, CA; Telesis Bio, San
Diego, CA; WPT Corp., Beaver Dam, KY;
Aldevron LLC, Fargo, ND; Ampulis,
Inc., West Chester, PA; BioBlue CMC/
Manufacturing Consulting LLC, San
Diego, CA; BioNet-Asia Co., Ltd.,
Bangkok, KINGDOM OF THAILAND;
Caplugs, Buffalo, NY; EKF Diagnostics,
Inc., Boerne, TX; Epimeron USA, Inc.
dba Willow Biosciences, Sunnyvale,
CA; Fitesa Simpsonville, Inc.,
Simpsonville, SC; Hills, Inc., West
Melbourne, FL; Hyacinth Proteins, Twin
Falls, ID; Premas Biotech Pvt, Ltd.,
Gurgaon, REPUBLIC OF INDIA;
Pyramid Labs, Costa Mesa, CA; Sarfez
Pharmaceuticals, Inc., Vienna, VA;
Technology Engineering Corp.,
Montgomery, AL; Valaria Technical
Consultants LLC, Westminster, MD;
Vedanta Biosciences, Inc., Cambridge,
MA; Vega Technology Group LLC,
North Canton, OH; Virginia Tech
Applied Research Corp., Arlington, VA;
Woodstock Sterile Solutions,
Woodstock, IL; American Nitrile
Operation LLC, Grove City, OH; Azzur
Cleanrooms-On Demand LLC, Devens,
MA; BlueHalo Labs LLC, Arlington, VA;
CENTRIENT PHARMACEUTICALS
INTERNATIONAL B.V., Delft,
KINGDOM OF THE NETHERLANDS;
Cascade Biocatalysts, Inc., Denver, CO;
Focus Industries Med LLC, Gold Beach,
OR; Genvax Technologies, Inc., Ames,
IA; HANS Scientific LLC, Farmington
Hills, MI; JLMillan Consulting LLC,
Evans, GA; Klim-Loc Medical, Inc.,
Carbondale, CO; Maxim Biomedical,
Inc., Rockville, MD; Q–VANT
Biosciences, Inc., Forestdale, MA; Sidra
Medical Supply, Inc., Elmont, NY;
Simon Williams Pharma Consulting
(SWPC) LLC, Gibbsboro, NJ; UNITED
STATES ANTIMONY CORPORATION,
E:\FR\FM\28FEN1.SGM
28FEN1
Federal Register / Vol. 90, No. 39 / Friday, February 28, 2025 / Notices
Thompson Falls, MT; Unicorn
Biotechnologies, Inc., Newark, NJ; and
Wacker Biotech US, Inc., San Diego, CA,
have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and the BioMaPConsortium intends to file additional
written notifications disclosing all
changes in membership.
On January 5, 2024, the BioMaPConsortium filed its original notification
pursuant to section 6(a) of the Act. The
Department of Justice published a notice
in the Federal Register pursuant to
section 6(b) of the Act on April 16, 2024
(89 FR 26923).
The last notification was filed with
the Department on October 3, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on December 20, 2024 (89 FR
104212).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2025–03217 Filed 2–27–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
khammond on DSK9W7S144PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Rust Foundation
Notice is hereby given that, on
January 8, 2025, pursuant to section 6(a)
of the National Cooperative Research
and Production Act of 1993, 15 U.S.C.
4301 et seq. (‘‘the Act’’), Rust
Foundation has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Adorsys Ireland Ltd.,
Dublin, IRELAND, has been added as a
party to this venture. Also, Shopify Inc.,
Ottawa, CANADA, has withdrawn as a
party to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and Rust
Foundation intends to file additional
written notifications disclosing all
changes in membership.
VerDate Sep<11>2014
16:18 Feb 27, 2025
Jkt 265001
On April 14, 2022, Rust Foundation
filed its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on May 13, 2022 (87 FR
29384).
The last notification was filed with
the Department on October 25, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on January 27, 2025 (90 FR 8223).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
10947
The last notification was filed with
the Department on October 1, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on December 2, 2024 (89 FR 95238).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2025–03211 Filed 2–27–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
[FR Doc. 2025–03202 Filed 2–27–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Countering Weapons of
Mass Destruction
Notice is hereby given that, on
January 6, 2025, pursuant to section 6(a)
of the National Cooperative Research
and Production Act of 1993, 15 U.S.C.
4301 et seq. (‘‘the Act’’), Countering
Weapons of Mass Destruction
(‘‘CWMD’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Active Optical Systems,
LLC, Albuquerque, NM; Oracle
America, Reston, VA; Univox LLC,
Tijeras, NM; Defense Operations &
Execution Solutions, Inc., West
Melbourne, FL; Gigantor Technologies,
Inc., Melbourne Beach, FL; Sensor
Technology Engineering, LLC, Santa
Barbara, CA; and Singletto, Inc., Seattle,
WA, have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and CWMD
intends to file additional written
notifications disclosing all changes in
membership.
On January 31, 2018, CWMD filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on March 12, 2018 (83 FR 10750).
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Integrated Photonics
Institute for Manufacturing Innovation
Operating Under the Name of the
American Institute for Manufacturing
Integrated Photonics
Notice is hereby given that, on
December 6, 2024, pursuant to section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), The
Integrated Photonics Institute for
Manufacturing Innovation operating
under the name of the American
Institute for Manufacturing Integrated
Photonics (‘‘AIM Photonics’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Canadian Photonics Fabrication Centre,
Ottawa, CANADA; and Dream
Photonics, Inc., Vancouver, CANADA,
have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and AIM
Photonics intends to file additional
written notifications disclosing all
changes in membership.
On June 16, 2016, AIM Photonics
filed its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on July 25, 2016 (81 FR
48450).
The last notification was filed with
the Department on October 14, 2024. A
notice was published in the Federal
E:\FR\FM\28FEN1.SGM
28FEN1
]]>Agencies
[Federal Register Volume 90, Number 39 (Friday, February 28, 2025)]
[Notices]
[Pages 10946-10947]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-03217]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Biopharmaceutical Manufacturing Preparedness
Consortium
Notice is hereby given that, on January 14, 2025, pursuant to
section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Biopharmaceutical
Manufacturing Preparedness Consortium (``BioMaP-Consortium'') has filed
written notifications simultaneously with the Attorney General and the
Federal Trade Commission disclosing changes in its membership. The
notifications were filed for the purpose of extending the Act's
provisions limiting the recovery of antitrust plaintiffs to actual
damages under specified circumstances.
Specifically, Bella Biologics, Inc., Cohoes, NY; Biotech Resources
Group LLC, Gaithersburg, MD; CellCo, San Francisco, CA; Mercury Bio,
Inc., Santa Fe, NM; Meridian Medical Technologies LLC, Columbia, MD;
National Institute for Pharmaceutical Technology and Education, Inc.,
Minneapolis, MN; Noramco LLC, Wilmington, DE; PATHOLOGY ASSIST-TEMP,
INC., Chantilly, VA; Parkdale Advanced Materials, Inc., Gastonia, NC;
Purisys LLC, Athens, GA; QYK BRANDS LLC, GARDEN GROVE, CA; Telesis Bio,
San Diego, CA; WPT Corp., Beaver Dam, KY; Aldevron LLC, Fargo, ND;
Ampulis, Inc., West Chester, PA; BioBlue CMC/Manufacturing Consulting
LLC, San Diego, CA; BioNet-Asia Co., Ltd., Bangkok, KINGDOM OF
THAILAND; Caplugs, Buffalo, NY; EKF Diagnostics, Inc., Boerne, TX;
Epimeron USA, Inc. dba Willow Biosciences, Sunnyvale, CA; Fitesa
Simpsonville, Inc., Simpsonville, SC; Hills, Inc., West Melbourne, FL;
Hyacinth Proteins, Twin Falls, ID; Premas Biotech Pvt, Ltd., Gurgaon,
REPUBLIC OF INDIA; Pyramid Labs, Costa Mesa, CA; Sarfez
Pharmaceuticals, Inc., Vienna, VA; Technology Engineering Corp.,
Montgomery, AL; Valaria Technical Consultants LLC, Westminster, MD;
Vedanta Biosciences, Inc., Cambridge, MA; Vega Technology Group LLC,
North Canton, OH; Virginia Tech Applied Research Corp., Arlington, VA;
Woodstock Sterile Solutions, Woodstock, IL; American Nitrile Operation
LLC, Grove City, OH; Azzur Cleanrooms-On Demand LLC, Devens, MA;
BlueHalo Labs LLC, Arlington, VA; CENTRIENT PHARMACEUTICALS
INTERNATIONAL B.V., Delft, KINGDOM OF THE NETHERLANDS; Cascade
Biocatalysts, Inc., Denver, CO; Focus Industries Med LLC, Gold Beach,
OR; Genvax Technologies, Inc., Ames, IA; HANS Scientific LLC,
Farmington Hills, MI; JLMillan Consulting LLC, Evans, GA; Klim-Loc
Medical, Inc., Carbondale, CO; Maxim Biomedical, Inc., Rockville, MD;
Q-VANT Biosciences, Inc., Forestdale, MA; Sidra Medical Supply, Inc.,
Elmont, NY; Simon Williams Pharma Consulting (SWPC) LLC, Gibbsboro, NJ;
UNITED STATES ANTIMONY CORPORATION,
[[Page 10947]]
Thompson Falls, MT; Unicorn Biotechnologies, Inc., Newark, NJ; and
Wacker Biotech US, Inc., San Diego, CA, have been added as parties to
this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and the BioMaP-Consortium intends to
file additional written notifications disclosing all changes in
membership.
On January 5, 2024, the BioMaP- Consortium filed its original
notification pursuant to section 6(a) of the Act. The Department of
Justice published a notice in the Federal Register pursuant to section
6(b) of the Act on April 16, 2024 (89 FR 26923).
The last notification was filed with the Department on October 3,
2024. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on December 20, 2024 (89 FR 104212).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2025-03217 Filed 2-27-25; 8:45 am]
BILLING CODE P
